For Q3, Jacobs guided, "we expect system-wide RevPAR growth to be flat to modestly down. We expect adjusted EBITDA of between $935 million and $955 million and diluted EPS adjusted for special items ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback